Cargando…

Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men

OBJECTIVE: We investigated the effects of 34 genetic risk variants for hyperglycemia/type 2 diabetes on lipoprotein subclasses and particle composition in a large population-based cohort. RESEARCH DESIGN AND METHODS: The study included 6,580 nondiabetic Finnish men from the population-based Metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Stančáková, Alena, Paananen, Jussi, Soininen, Pasi, Kangas, Antti J., Bonnycastle, Lori L., Morken, Mario A., Collins, Francis S., Jackson, Anne U., Boehnke, Michael L., Kuusisto, Johanna, Ala-Korpela, Mika, Laakso, Markku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292337/
https://www.ncbi.nlm.nih.gov/pubmed/21421807
http://dx.doi.org/10.2337/db10-1655
_version_ 1782225262917713920
author Stančáková, Alena
Paananen, Jussi
Soininen, Pasi
Kangas, Antti J.
Bonnycastle, Lori L.
Morken, Mario A.
Collins, Francis S.
Jackson, Anne U.
Boehnke, Michael L.
Kuusisto, Johanna
Ala-Korpela, Mika
Laakso, Markku
author_facet Stančáková, Alena
Paananen, Jussi
Soininen, Pasi
Kangas, Antti J.
Bonnycastle, Lori L.
Morken, Mario A.
Collins, Francis S.
Jackson, Anne U.
Boehnke, Michael L.
Kuusisto, Johanna
Ala-Korpela, Mika
Laakso, Markku
author_sort Stančáková, Alena
collection PubMed
description OBJECTIVE: We investigated the effects of 34 genetic risk variants for hyperglycemia/type 2 diabetes on lipoprotein subclasses and particle composition in a large population-based cohort. RESEARCH DESIGN AND METHODS: The study included 6,580 nondiabetic Finnish men from the population-based Metabolic Syndrome in Men (METSIM) study (aged 57 ± 7 years; BMI 26.8 ± 3.7 kg/m(2)). Genotyping of 34 single nucleotide polymorphism (SNPs) for hyperglycemia/type 2 diabetes was performed. Proton nuclear magnetic resonance spectroscopy was used to measure particle concentrations of 14 lipoprotein subclasses and their composition in native serum samples. RESULTS: The glucose-increasing allele of rs780094 in GCKR was significantly associated with low concentrations of VLDL particles (independently of their size) and small LDL and was nominally associated with low concentrations of intermediate-density lipoprotein, all LDL subclasses, and high concentrations of very large and large HDL particles. The glucose-increasing allele of rs174550 in FADS1 was significantly associated with high concentrations of very large and large HDL particles and nominally associated with low concentrations of all VLDL particles. SNPs rs10923931 in NOTCH2 and rs757210 in HNF1B genes showed nominal or significant associations with several lipoprotein traits. The genetic risk score of 34 SNPs was not associated with any of the lipoprotein subclasses. CONCLUSIONS: Four of the 34 risk loci for type 2 diabetes or hyperglycemia (GCKR, FADS1, NOTCH2, and HNF1B) were significantly associated with lipoprotein traits. A GCKR variant predominantly affected the concentration of VLDL, and the FADS1 variant affected very large and large HDL particles. Only a limited number of risk loci for hyperglycemia/type 2 diabetes significantly affect lipoprotein metabolism.
format Online
Article
Text
id pubmed-3292337
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-32923372012-05-01 Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men Stančáková, Alena Paananen, Jussi Soininen, Pasi Kangas, Antti J. Bonnycastle, Lori L. Morken, Mario A. Collins, Francis S. Jackson, Anne U. Boehnke, Michael L. Kuusisto, Johanna Ala-Korpela, Mika Laakso, Markku Diabetes Genetics OBJECTIVE: We investigated the effects of 34 genetic risk variants for hyperglycemia/type 2 diabetes on lipoprotein subclasses and particle composition in a large population-based cohort. RESEARCH DESIGN AND METHODS: The study included 6,580 nondiabetic Finnish men from the population-based Metabolic Syndrome in Men (METSIM) study (aged 57 ± 7 years; BMI 26.8 ± 3.7 kg/m(2)). Genotyping of 34 single nucleotide polymorphism (SNPs) for hyperglycemia/type 2 diabetes was performed. Proton nuclear magnetic resonance spectroscopy was used to measure particle concentrations of 14 lipoprotein subclasses and their composition in native serum samples. RESULTS: The glucose-increasing allele of rs780094 in GCKR was significantly associated with low concentrations of VLDL particles (independently of their size) and small LDL and was nominally associated with low concentrations of intermediate-density lipoprotein, all LDL subclasses, and high concentrations of very large and large HDL particles. The glucose-increasing allele of rs174550 in FADS1 was significantly associated with high concentrations of very large and large HDL particles and nominally associated with low concentrations of all VLDL particles. SNPs rs10923931 in NOTCH2 and rs757210 in HNF1B genes showed nominal or significant associations with several lipoprotein traits. The genetic risk score of 34 SNPs was not associated with any of the lipoprotein subclasses. CONCLUSIONS: Four of the 34 risk loci for type 2 diabetes or hyperglycemia (GCKR, FADS1, NOTCH2, and HNF1B) were significantly associated with lipoprotein traits. A GCKR variant predominantly affected the concentration of VLDL, and the FADS1 variant affected very large and large HDL particles. Only a limited number of risk loci for hyperglycemia/type 2 diabetes significantly affect lipoprotein metabolism. American Diabetes Association 2011-05 2011-04-23 /pmc/articles/PMC3292337/ /pubmed/21421807 http://dx.doi.org/10.2337/db10-1655 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Genetics
Stančáková, Alena
Paananen, Jussi
Soininen, Pasi
Kangas, Antti J.
Bonnycastle, Lori L.
Morken, Mario A.
Collins, Francis S.
Jackson, Anne U.
Boehnke, Michael L.
Kuusisto, Johanna
Ala-Korpela, Mika
Laakso, Markku
Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men
title Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men
title_full Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men
title_fullStr Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men
title_full_unstemmed Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men
title_short Effects of 34 Risk Loci for Type 2 Diabetes or Hyperglycemia on Lipoprotein Subclasses and Their Composition in 6,580 Nondiabetic Finnish Men
title_sort effects of 34 risk loci for type 2 diabetes or hyperglycemia on lipoprotein subclasses and their composition in 6,580 nondiabetic finnish men
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292337/
https://www.ncbi.nlm.nih.gov/pubmed/21421807
http://dx.doi.org/10.2337/db10-1655
work_keys_str_mv AT stancakovaalena effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT paananenjussi effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT soininenpasi effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT kangasanttij effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT bonnycastleloril effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT morkenmarioa effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT collinsfranciss effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT jacksonanneu effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT boehnkemichaell effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT kuusistojohanna effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT alakorpelamika effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen
AT laaksomarkku effectsof34risklocifortype2diabetesorhyperglycemiaonlipoproteinsubclassesandtheircompositionin6580nondiabeticfinnishmen